CalciMedica is a privately held, clinical-stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflammatory diseases. 

Biotechnology

Education

CalciMedica

A. Rachel Leheny

Raven D. Jaeger

Andrew Cunningham

Eric W. Roberts

Daniel Geffken

Michael J. Dunn

Kenneth A. Stauderman

John M. Dunn

Sudarshan Hebbar

The board of directors at CalciMedica has a history of experience with founding and chairing various companies and organizations in the medical industry. They also each have a wealth of medical knowledge, with degrees from renowned universities in medicine and medical science.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at CalciMedica

Leadership Team

CEO and Executive Team